Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

by Kang-Shuai Li, Sen Guo, Yu-Xin Chen, Zong-Li Zhang
Published 2022-12-01

Establishment and validation of a nomogram containing cytokeratin fragment antigen 21-1 for the differential diagnosis of intrahepatic cholangiocarcinoma and hepatocellular carcino...

by Yuan-Yuan Liu, Yue-Yue Li, Yong-Shuai Liu, Zong-Li Zhang, Yan-Jing Gao
Published 2024-06-01

BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt/β-catenin pathway

by Jian-Hua Chang, Bo-Wen Xu, Di Shen, Wei Zhao, Yue Wang, Jia-liang Liu, Guang-Xiao Meng, Guang-Zhen Li, Zong-Li Zhang
Published 2023-03-01

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma

by Li-ming Zhao, An-da Shi, Yan Yang, Zeng-li Liu, Zeng-li Liu, Xiao-Qiang Hu, Li-Zhuang Shu, Yong-chang Tang, Zong-li Zhang
Published 2023-03-01

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers

by Yun-cheng Li, Kang-shuai Li, Zeng-li Liu, Yong-chang Tang, Xiao-Qiang Hu, Xing-yong Li, An-da Shi, Li-ming Zhao, Li-Zhuang Shu, Shuo Lian, Zhang-di Yan, Shao-hui Huang, Guo-li Sheng, Yan Song, Yun-jia Liu, Fan Huan, Ming-hui Zhang, Zong-li Zhang
Published 2022-10-01